Literature DB >> 14661817

ACE genotype and physical training effects: a randomized study among elderly Danes.

Henrik Frederiksen1, Lise Bathum, Charlotte Worm, Kaare Christensen, Lis Puggaard.   

Abstract

BACKGROUND AND AIMS: The level of physical functioning (PF) late in life has, in recent years, been shown to be influenced by genetic factors. One of the most extensively studied genetic variants associated with PF and trainability is insertion/deletion (I/D) polymorphism in the gene encoding Angiotensin Converting Enzyme (ACE). However, ACE studies have mainly been conducted among younger persons in excellent physical shape. In this study, we examine whether the level of PF, trainability, or rate-of-change are associated with the ACE genotype among the elderly.
METHODS: We used data from 4 randomized training studies of elderly Danes (N = 203). The measures of PF were self-report, maximal oxygen uptake, muscle strength, walking speed, and body composition.
RESULTS: Overall, a favorable change in the measures of PF was observed in training groups compared with control groups. However, within groups, neither pre- or post-training/control period levels of PF nor differences in pre- and post-levels were associated with the ACE genotype.
CONCLUSIONS: On the basis of our randomized studies, we could not detect any association between the ACE genotype and the level of PF or change, regardless of whether response to physical training or spontaneous changes was studied.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14661817     DOI: 10.1007/bf03324510

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  12 in total

1.  Angiotensin-converting enzyme (ACE) genotypes and disability in hospitalized older patients.

Authors:  Davide Seripa; Giulia Paroni; Maria G Matera; Carolina Gravina; Carlo Scarcelli; Michele Corritore; Luigi P D'Ambrosio; Maria Urbano; Grazia D'Onofrio; Massimiliano Copetti; Patrick G Kehoe; Francesco Panza; Alberto Pilotto
Journal:  Age (Dordr)       Date:  2010-11-13

2.  Gene driven power athletes? Genetic variation in muscular strength and power.

Authors:  G Beunen; M Thomis
Journal:  Br J Sports Med       Date:  2006-10       Impact factor: 13.800

Review 3.  Sarcopenia: diagnosis and treatment.

Authors:  J E Morley
Journal:  J Nutr Health Aging       Date:  2008 Aug-Sep       Impact factor: 4.075

Review 4.  Validated treatments and therapeutics prospectives regarding pharmacological products for sarcopenia.

Authors:  G Onder; C Della Vedova; F Landi
Journal:  J Nutr Health Aging       Date:  2009-10       Impact factor: 4.075

Review 5.  The ACE gene and human performance: 12 years on.

Authors:  Zudin Puthucheary; James R A Skipworth; Jai Rawal; Mike Loosemore; Ken Van Someren; Hugh E Montgomery
Journal:  Sports Med       Date:  2011-06-01       Impact factor: 11.136

Review 6.  Molecular genetic studies of gene identification for sarcopenia.

Authors:  Li-Jun Tan; Shan-Lin Liu; Shu-Feng Lei; Christopher J Papasian; Hong-Wen Deng
Journal:  Hum Genet       Date:  2011-06-26       Impact factor: 4.132

Review 7.  Genes and the ageing muscle: a review on genetic association studies.

Authors:  Nuria Garatachea; Alejandro Lucía
Journal:  Age (Dordr)       Date:  2011-10-27

Review 8.  Genetic influences in sport and physical performance.

Authors:  Zudin Puthucheary; James R A Skipworth; Jai Rawal; Mike Loosemore; Ken Van Someren; Hugh E Montgomery
Journal:  Sports Med       Date:  2011-10-01       Impact factor: 11.136

9.  Single and combined influence of ACE and ACTN3 genotypes on muscle phenotypes in octogenarians.

Authors:  Nuria Garatachea; Carmen Fiuza-Luces; Gema Torres-Luque; Thomas Yvert; Catalina Santiago; Félix Gómez-Gallego; Jonatan R Ruiz; Alejandro Lucia
Journal:  Eur J Appl Physiol       Date:  2011-11-02       Impact factor: 3.078

Review 10.  Genetic variations underlying self-reported physical functioning: a review.

Authors:  Melissa S Y Thong; Mirjam A G Sprangers; Jeff A Sloan; Donald L Patrick; Ping Yang; Cornelis J F van Noorden
Journal:  Qual Life Res       Date:  2014-11-12       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.